|
Professor of Biological Sciences; Robert and Jane Meyerhoff Chair of Biochemistry
Postdoctoral, Johns Hopkins University, 1977; Ph.D., California Institute of Technology, 1975
presentations
Immune Suppression, Inflammation, and Tumor Progression
Medical University of South Carolina
January 8, 2008
Immune Suppression, Inflammation, and Tumor Progression
S. Ostrand-Rosenberg
FDA, Washington, DC
March 7, 2008
Immune surveillance against cancer: a balance between pro- and anti-tumor immunity
Molecular Biology in Clinical Oncology
S. Ostrand-Rosenberg
Aspen, CO (July 11-18, 2008)
July 16, 2009
Uveal melanoma MHC II vaccines activate tumor-specific cytotoxic T cells and block induction of inhibitor costimulatory molecules
International Congress of Eye Research (ICER)
S. Ostrand-Rosenberg, J. Bosch,U. Iheagawara, and M. Srivastava
Beijing, China (Sept. 24-29, 2008)
September 28, 2009
Inflammation-activated myeloid-derived suppressor cells promote tumor progression and metastasis
Chemical and Biological Aspects of Inflammation and Cancer
S. Ostrand-Rosenberg
ko Olina, Oahu, Hawaii (Oct. 14-17, 2008)
October 17, 2008
Uveal melanoma MHC II vaccines for the treatment of metastatic uveal melanoma
American Association of Ophthalmology and European Society of Ophthalmology Joint Conference
S. Ostrand-Rosenberg, J. Bosch, and U. Iheagawara
Atlanta, GA, Nov. 7-11, 2008
November 11, 2008
Inflammation-drived myeloid-derived suppressor cells: co-opting anti-tumor immunity to promote tumor progression
American Association of Cancer Research: Frontiers in Cancer Prevention
S. Ostrand-Rosenberg
Washington, DC Nov. 16-19, 2008
November 2, 2008
Understanding Cancer
American Association of Cancer Research: Frontiers in Cancer Prevention
S. Ostrand-Rosenberg
Washington, DC Nov. 16-19, 2008
November 18, 2008
Tumor Induced Immune Suppression: The Inflammation Connection
American Association of Cancer Research: Tumor Immunology: New Perspectives
S. Ostrand-Rosenberg
Miami, FL, (Dec. 2-5, 2008)
December 4, 2008
|
